Epinomics approached us with the vision to form a platform ecosystem that leverages deep analytics and processes large data sets to decode the epigenome in order to make sense of personalized medicine data.
Our engineering team was responsible for the design, solution architecture, development, and maintenance of the platform that enables data processing and interaction between Epinomics scientists and their clients as well as partners. It allows users to enter sample data, choose the type of analysis they wanted to run, and keep track of sample processing stages. We also transferred the solution from a monolithic to a microservices architecture which ensured greater flexibility, easier maintenance, and scalability.
Epinomics is revolutionizing personalized medicine through scientific research and deep analytics. Being dedicated to the vision to decode the programming of our genome to drive personalized medicine and proprietary epigenomics technology with 1000x improvement over existing technologies to impact drug development and clinical applications. Since 2018 Epinomics has been acquired by 10x Genomics.
"Furthers 10x Leadership across Genomics Applications Brings Inventors of ATAC-seq Technology to 10x"
Midas Healthcare GmbH, a pharmaceutical leader from Ingelheim, Germany, engaged us along with another marketing agency to develop the website of their new brand ‘LaVieCal’.
We developed a brand strategy to Maddox AI that communicates the company’s values, messaging and personality through updated styles and layout.
One of the leading Global Pharmaceutical Retailers approached us to develop a global design system.
